The purpose of this study is to study how CMVIG interacts with the body and to see if it might work to prevent kidney transplant patients from becoming infecte…

Kidney Transplant; ComplicationsCMV

~Estimated

~$10 – $6,250

University of MinnesotaNCT07096453

Phase 2

A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe Maternal Acquired CMV Infection

Patients with moderate or severe CMV disease less than 21 days old who have a maternal donor who has a CMV response to the peptivators will be screened. All p…

Congenital Cytomegaloviral (CMV) Disease

~Estimated

~$10 – $6,250

New York Medical CollegeNCT05564598

← PreviousPage 2 of 2Next →